Press Release Details

View all news
July 28, 2010
Ironwood Pharmaceuticals Announces Upcoming Presentation at Wedbush Life Sciences MAC Best Ideas 2010

CAMBRIDGE, Mass., Jul 28, 2010 (BUSINESS WIRE) -- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that Michael Higgins, Ironwood's chief financial officer and chief operating officer, will present at Wedbush Life Sciences MAC Best Ideas 2010 on Tuesday, August 3, 2010 at 8:35 a.m. Eastern Time at Le Parker Meridien Hotel in New York.

A live webcast of Ironwood's presentation will be accessible through the Investors section of the company's website at www.ironwoodpharma.com. To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start of the presentation to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwood's website for 14 days following the conference.

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwood's GC-C agonist, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is located in Cambridge, Mass.

.

SOURCE: Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals
Susan Brady, 617-621-8304
Corporate Communications
sbrady@ironwoodpharma.com

Copyright Business Wire 2010

Categories: Press Releases
View all news